ELDN - Company ID 0001404281
Eledon Pharmaceuticals, Inc. trades as ELDN. This page tracks Eledon Pharmaceuticals, Inc. through 596 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| EFFECT | - | 2026-05-11 |
| Securities registration | S-3 | 2026-05-01 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
The largest companies sharing Eledon Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Eledon Pharmaceuticals, Inc. reported a net loss of $45.62M.